[1]
Pourakbari, B.; Rezaizadeh, G.; Mahmoudi, S.; Mamishi, S. Epidemiology of nosocomial infections in pediatric patients in an Iranian referral hospital. J. Prev. Med. Hyg., 2012, 53(4), 204-206.
[2]
Buys, H.; Muloiwa, R.; Bamford, C.; Eley, B. Klebsiella pneumoniae bloodstream infections at a South African children’s hospital 2006-2011, a cross-sectional study. BMC Infect. Dis., 2016, 16(1), 570.
[3]
Pourakbari, B.; Ferdosian, F.; Mahmoudi, S.; Teymuri, M.; Sabouni, F.; Heydari, H.; Ashtiani, M.T.; Mamishi, S. Increase resistant rates and ESBL production between E. coli isolates causing urinary tract infection in young patients from Iran. Braz. J. Microbiol., 2012, 43(2), 766-769.
[4]
Tal Jasper, R.; Coyle, J.R.; Katz, D.E.; Marchaim, D. The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae. Future Microbiol., 2015, 10(5), 819-839.
[5]
Pitout, J.D.; Nordmann, P.; Laupland, K.B.; Poirel, L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J. Antimicrob. Chemother., 2005, 56(1), 52-59.
[6]
Colodner, R.; Rock, W.; Chazan, B.; Keller, N.; Guy, N.; Sakran, W.; Raz, R. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur. J. Clin. Microbiol. Infect. Dis., 2004, 23(3), 163-167.
[7]
Ben-Ami, R.; Rodríguez-Baño, J.; Arslan, H.; Pitout, J.D.; Quentin, C.; Calbo, E.S.; Azap, O.K.; Arpin, C.; Pascual, A.; Livermore, D.M.; Garau, J.; Carmeli, Y. A multinational survey of risk factors for infection with extended-spectrum β-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin. Infect. Dis., 2009, 49(5), 682-690.
[8]
Liakopoulos, A.; Mevius, D.; Ceccarelli, D. A Review of SHV Extended-Spectrum β-Lactamases: Neglected Yet Ubiquitous. Front. Microbiol., 2016, 7, 1374.
[9]
Stapleton, P.J.; Murphy, M.; McCallion, N.; Brennan, M.; Cunney, R.; Drew, R.J. Outbreaks of extended spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units: a systematic review. Arch. Dis. Child. Fetal Neonatal Ed., 2016, 101(1), F72-F78.
[10]
Naas, T.; Cuzon, G.; Robinson, A.L.; Andrianirina, Z.; Imbert, P.; Ratsima, E.; Ranosiarisoa, Z.N.; Nordmann, P.; Raymond, J. Neonatal infections with multidrug-resistant ESBL-producing E. cloacae and K. pneumoniae in Neonatal Units of two different Hospitals in Antananarivo, Madagascar. BMC Infect. Dis., 2016, 16, 275.
[11]
Du, B.; Long, Y.; Liu, H.; Chen, D.; Liu, D.; Xu, Y.; Xie, X. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med., 2002, 28(12), 1718-1723.
[12]
Lautenbach, E.; Patel, J.B.; Bilker, W.B.; Edelstein, P.H.; Fishman, N.O. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin. Infect. Dis., 2001, 32(8), 1162-1171.
[13]
Garner, J.S.; Jarvis, W.R.; Emori, T.G.; Horan, T.C.; Hughes, J.M. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control, 1988, 16(3), 128-140.
[14]
Clinical Laboratory Standard Institute. Performance
Standards for Antimicrobial Susceptibility Testing;
Twenty-Second Informational Supplement. Vol. 33.
Wayne, Pennsylvania, USA: Clinical Laboratory
Standard Institute, 2013.
[15]
Pourakbari, B. Molecular characterization of extended spectrum beta-lactamase among escherichia coli clinical isolates causing urinary tract infections in an iranian referral pediatrics center.,
[16]
Deschaght, P.; Van Simaey, L.; Decat, E.; Van Mechelen, E.; Brisse, S.; Vaneechoutte, M. Rapid genotyping of Achromobacter xylosoxidans, Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolates using melting curve analysis of RAPD-generated DNA fragments (McRAPD). Res. Microbiol., 2011, 162(4), 386-392.
[17]
Turton, J.F.; Kaufmann, M.E.; Warner, M.; Coelho, J.; Dijkshoorn, L.; van der Reijden, T.; Pitt, T.L. A prevalent, multiresistant clone of Acinetobacter baumannii in Southeast England. J. Hosp. Infect., 2004, 58(3), 170-179.
[18]
Reinert, R.R.; Low, D.E.; Rossi, F.; Zhang, X.; Wattal, C.; Dowzicky, M.J. Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J. Antimicrob. Chemother., 2007, 60(5), 1018-1029.
[19]
Bradford, P.A. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev., 2001, 14(4), 933-951.
[20]
Cantón, R.; González-Alba, J.M.; Galán, J.C.; Enzymes, C.T.X-M. Origin and Diffusion. Front. Microbiol., 2012, 3, 110.
[21]
Feizabadi, M.M.; Mahamadi-Yeganeh, S.; Mirsalehian, A.; Mirafshar, S.M.; Mahboobi, M.; Nili, F.; Yadegarinia, D. Genetic characterization of ESBL producing strains of Klebsiella pneumoniae from Tehran hospitals. J. Infect. Dev. Ctries., 2010, 4(10), 609-615.
[22]
Calbo, E.; Garau, J. The changing epidemiology of hospital outbreaks due to ESBL-producing Klebsiella pneumoniae: the CTX-M-15 type consolidation. Future Microbiol., 2015, 10(6), 1063-1075.
[23]
Latifpour, M.; Gholipour, A.; Damavandi, M.S. Prevalence of Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae Isolates in Nosocomial and Community-Acquired Urinary Tract Infections. Jundishapur J. Microbiol., 2016, 9(3), e31179.
[24]
Mansury, D.; Motamedifar, M.; Sarvari, J.; Shirazi, B.; Khaledi, A. Antibiotic susceptibility pattern and identification of extended spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae from Shiraz, Iran. Iran. J. Microbiol., 2016, 8(1), 55-61.
[25]
Roy, S.; Gaind, R.; Chellani, H.; Mohanty, S.; Datta, S.; Singh, A.K.; Basu, S. Neonatal septicaemia caused by diverse clones of Klebsiella pneumoniae & Escherichia coli harbouring blaCTX-M-15. Indian J. Med. Res., 2013, 137(4), 791-799.
[26]
Rodriguez-Villalobos, H.; Bogaerts, P.; Berhin, C.; Bauraing, C.; Deplano, A.; Montesinos, I.; de Mendonça, R.; Jans, B.; Glupczynski, Y. Trends in production of extended-spectrum β-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. J. Antimicrob. Chemother., 2011, 66(1), 37-47.
[27]
Hawkey, P.M.; Jones, A.M. The changing epidemiology of resistance. J. Antimicrob. Chemother., 2009, 64(Suppl. 1), i3-i10.
[28]
Bush, K. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr. Opin. Microbiol., 2010, 13(5), 558-564.
[29]
Cantón, R.; Coque, T.M. The CTX-M β-lactamase pandemic. Curr. Opin. Microbiol., 2006, 9(5), 466-475.
[30]
Woodford, N.; Turton, J.F.; Livermore, D.M. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev., 2011, 35(5), 736-755.
[31]
Geraci, D.M.; Bonura, C.; Giuffrè, M.; Saporito, L.; Graziano, G.; Aleo, A.; Fasciana, T.; Di Bernardo, F.; Stampone, T.; Palma, D.M.; Mammina, C. Is the monoclonal spread of the ST258, KPC-3-producing clone being replaced in southern Italy by the dissemination of multiple clones of carbapenem-nonsusceptible, KPC-3-producing Klebsiella pneumoniae? Clin. Microbiol. Infect., 2015, 21(3), e15-e17.
[32]
Bonura, C.; Giuffrè, M.; Aleo, A.; Fasciana, T.; Di Bernardo, F.; Stampone, T.; Giammanco, A.; Palma, D.M.; Mammina, C. An update of the evolving epidemic of blaKPC carrying Klebsiella pneumoniae in Sicily, Italy, 2014: emergence of multiple non-ST258 clones. PLoS One, 2015, 10(7), e0132936.
[33]
Abdel-Hady, H.; Hawas, S.; El-Daker, M.; El-Kady, R. Extended-spectrum β-lactamase producing Klebsiella pneumoniae in neonatal intensive care unit. J. Perinatol., 2008, 28(10), 685-690.
[34]
Brady, M.T. Health care-associated infections in the neonatal intensive care unit. Am. J. Infect. Control, 2005, 33(5), 268-275.
[35]
Martinez-Aguilar, G.; Alpuche-Aranda, C.M.; Anaya, C.; Alcantar-Curiel, D.; Gayosso, C.; Daza, C.; Mijares, C.; Tinoco, J.C.; Santos, J.I. Outbreak of nosocomial sepsis and pneumonia in a newborn intensive care unit by multiresistant extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: high impact on mortality. Infect. Control Hosp. Epidemiol., 2001, 22(11), 725-728.
[36]
Coque, T.M.; Baquero, F.; Canton, R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill., 2008, 13(47), 19044.
[37]
Rettedal, S.; Löhr, I.H.; Natås, O.; Giske, C.G.; Sundsfjord, A.; Øymar, K. First outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a Norwegian neonatal intensive care unit; associated with contaminated breast milk and resolved by strict cohorting. APMIS, 2012, 120(8), 612-621.
[38]
Schwaber, M.J.; Navon-Venezia, S.; Kaye, K.S.; Ben-Ami, R.; Schwartz, D.; Carmeli, Y. Clinical and economic impact of bacteremia with extended- spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob. Agents Chemother., 2006, 50(4), 1257-1262.
[39]
Schwaber, M.J.; Navon-Venezia, S.; Schwartz, D.; Carmeli, Y. High levels of antimicrobial coresistance among extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob. Agents Chemother., 2005, 49(5), 2137-2139.
[40]
Mamishi, S.; Pourakbari, B.; Teymuri, M.; Babamahmoodi, A.; Mahmoudi, S. Management of hospital infection control in iran: a need for implementation of multidisciplinary approach. Osong Public Health Res. Perspect., 2014, 5(4), 179-186.
47
5